Position in LLY
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$278,961,642
-$58,902,735 QoQ
Shares Held
303,295
-3.5% QoQ
Ownership
0.032%
of shares outstanding
% of Portfolio
1.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026COMMONWEALTH EQUITY SERVICES, LLC holds $1,341,272,655 across 18 Drug Manufacturers - General names. LLY ranks #2 (20.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,276,418 | $312,007,615 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
303,295 | $278,961,642 | |
| 3 | ABBV |
AbbVie Inc.
|
1,000,714 | $217,645,287 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,222,577 | $147,063,787 | |
| 5 | AMGN |
Amgen Inc
|
319,923 | $112,564,907 | |
| 6 | PFE |
Pfizer Inc
|
3,488,515 | $97,957,501 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
992,662 | $60,204,950 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
258,398 | $36,012,929 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $278,961,642 | 303,295 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $337,864,377 | 314,386 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $269,448,872 | 353,144 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $289,596,954 | 371,502 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $311,549,770 | 377,220 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $277,824,272 | 359,876 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $324,470,209 | 366,244 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $334,919,980 | 369,922 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $282,633,645 | 363,301 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $206,683,029 | 354,565 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $181,068,671 | 337,104 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $154,693,053 | 329,850 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $113,167,536 | 329,531 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $126,441,254 | 345,619 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $113,258,834 | 350,267 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $113,822,562 | 351,055 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $95,781,028 | 334,466 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $91,588,198 | 331,577 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $74,860,662 | 324,002 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $74,297,919 | 323,710 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $54,682,400 | 292,701 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $46,355,528 | 274,553 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $41,266,643 | 278,791 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $40,354,458 | 245,794 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $33,255,484 | 239,731 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||